These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25047363)

  • 41. Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison.
    Stöhr R; Dohmen G; Herpertz R; Brehmer K; Aktug O; Koos R; Altiok E; Stegemann E; Autschbach R; Marx N; Hoffmann R
    Coron Artery Dis; 2011 Dec; 22(8):595-600. PubMed ID: 22009042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcatheter aortic valve replacement for advanced valvular disease in active SLE and APS.
    Bert JS; Abdullah M; Dahle TG; Gertner E
    Lupus; 2013 Sep; 22(10):1046-9. PubMed ID: 23884983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current status of transcatheter aortic valve replacement.
    Webb JG; Wood DA
    J Am Coll Cardiol; 2012 Aug; 60(6):483-92. PubMed ID: 22749306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of wait times on late postprocedural mortality after successful transcatheter aortic valve replacement.
    Roule V; Rebouh I; Lemaitre A; Sabatier R; Blanchart K; Briet C; Bignon M; Beygui F
    Sci Rep; 2022 Apr; 12(1):5967. PubMed ID: 35395869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients.
    Piazza N; Kalesan B; van Mieghem N; Head S; Wenaweser P; Carrel TP; Bleiziffer S; de Jaegere PP; Gahl B; Anderson RH; Kappetein AP; Lange R; Serruys PW; Windecker S; Jüni P
    JACC Cardiovasc Interv; 2013 May; 6(5):443-51. PubMed ID: 23702009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inequity in Access to Transcatheter Aortic Valve Replacement: A Pan-Canadian Evaluation of Wait-Times.
    Wijeysundera HC; Henning KA; Qiu F; Adams C; Al Qoofi F; Asgar A; Austin P; Bainey KR; Cohen EA; Daneault B; Fremes S; Kass M; Ko DT; Lambert L; Lauck SB; MacFarlane K; Nadeem SN; Oakes G; Paddock V; Pelletier M; Peterson M; Piazza N; Potter BJ; Radhakrishnan S; Rodes-Cabau J; Toleva O; Webb JG; Welsh R; Wood D; Woodward G; Zimmermann R
    Can J Cardiol; 2020 Jun; 36(6):844-851. PubMed ID: 32349882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study.
    Meredith IT; Worthley SG; Whitbourn RJ; Antonis P; Montarello JK; Newcomb AE; Lockwood S; Haratani N; Allocco DJ; Dawkins KD
    EuroIntervention; 2014 Mar; 9(11):1264-70. PubMed ID: 24169077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrieval of ruptured valves and their accessories during transcatheter aortic valve replacement.
    Negi SI; Loyalka P; Gregoric I; Kar B
    J Card Surg; 2014 Mar; 29(2):209-12. PubMed ID: 24417302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients.
    Osnabrugge RL; Head SJ; Genders TS; Van Mieghem NM; De Jaegere PP; van der Boon RM; Kerkvliet JM; Kalesan B; Bogers AJ; Kappetein AP; Hunink MG
    Ann Thorac Surg; 2012 Dec; 94(6):1954-60. PubMed ID: 22959568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcatheter versus surgical aortic valve replacement in patients with prior coronary artery bypass graft operation: a PARTNER trial subgroup analysis.
    Greason KL; Mathew V; Suri RM; Holmes DR; Rihal CS; McAndrew T; Xu K; Mack M; Webb JG; Pichard A; Williams M; Leon MB; Svensson L; Thourani V; Smith CR
    Ann Thorac Surg; 2014 Jul; 98(1):1-7; discussion 7-8. PubMed ID: 24881859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.
    Eggebrecht H; Schäfer U; Treede H; Boekstegers P; Babin-Ebell J; Ferrari M; Möllmann H; Baumgartner H; Carrel T; Kahlert P; Lange P; Walther T; Erbel R; Mehta RH; Thielmann M
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1218-27. PubMed ID: 22115663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness considerations in transcatheter management of valvular heart disease.
    Gadey G; Reynolds MR
    Can J Cardiol; 2014 Sep; 30(9):1058-63. PubMed ID: 24999170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial.
    Dewey TM; Bowers B; Thourani VH; Babaliaros V; Smith CR; Leon MB; Svensson LG; Tuzcu EM; Miller DC; Teirstein PS; Tyner J; Brown DL; Fontana GP; Makkar RR; Williams MR; George I; Kirtane AJ; Bavaria JE; Mack MJ
    Ann Thorac Surg; 2013 Dec; 96(6):2083-9. PubMed ID: 23968764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early experience of a transcatheter aortic valve program at a Veterans Affairs facility.
    Omer S; Kar B; Cornwell LD; Blaustein A; Levine GN; Ali N; Jneid H; Paniagua D; Atluri PV; Bechara CF; Kougias P; Ruma M; Preventza O; Bozkurt B; Carabello BA; Bakaeen FG
    JAMA Surg; 2013 Dec; 148(12):1087-93. PubMed ID: 24048246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of procedural capacity on transcatheter aortic valve replacement wait times and outcomes: a study of regional variation in Ontario, Canada.
    Henning KA; Ravindran M; Qiu F; Fam NP; Seth TN; Austin PC; Wijeysundera HC
    Open Heart; 2020 May; 7(1):. PubMed ID: 32393658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: summary assessment of the California Technology Assessment Forum.
    Tice JA; Sellke FW; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):482-91.e6. PubMed ID: 24252939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring wait times for transcatheter aortic valve implantation: a need for national benchmarks.
    Lauck S; Stub D; Webb J
    Can J Cardiol; 2014 Oct; 30(10):1150-2. PubMed ID: 25154044
    [No Abstract]   [Full Text] [Related]  

  • 60. Transcatheter aortic valve replacement: focus on sex-related differences in outcomes.
    Flaherty MP; Grubb KJ
    Am J Cardiovasc Drugs; 2015 Apr; 15(2):95-101. PubMed ID: 25752476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.